The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Buclizine Market Research Report 2025

Global Buclizine Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1582154

No of Pages : 122

Ask Your Query

Synopsis

Buclizine is an antihistamine and anticholinergic of the diphenylmethylpiperazine group. It is considered to be an antiemetic, similar to meclizine.

Global Buclizine market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Buclizine market research.

Key manufacturers engaged in the Buclizine industry include Stuart Pharmaceuticals, Laboratorios Rocnarf, UCB, Mankind Pharma, Johnson and Johnson, Meider Pharma, Sanofi, MK Pharma and HUA Shin Chemical Pharmaceutical, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % volume of Buclizine were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Buclizine market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Buclizine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  •     Stuart Pharmaceuticals
  •     Laboratorios Rocnarf
  •     UCB
  •     Mankind Pharma
  •     Johnson and Johnson
  •     Meider Pharma
  •     Sanofi
  •     MK Pharma
  •     HUA Shin Chemical Pharmaceutical
  •     Peili Pharmaceutical
  •     Pfizer
  •     Sinphar
  •     Al Pharm

Segment by Type

  •     Hospital
  •     Drug Store

Segment by Application

  •     Antiallergic Agent
  •     Histamine H₁-Receptor Antagonist

Consumption by Region

  •  North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

The Buclizine report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

 

 1.1 Product Overview and Scope of Buclizine
    1.2 Buclizine Segment by Type
        1.2.1 Global Buclizine Market Value Comparison by Type (2023-2029)
        1.2.2 Hospital
        1.2.3 Drug Store
    1.3 Buclizine Segment by Application
        1.3.1 Global Buclizine Market Value by Application: (2023-2029)
        1.3.2 Antiallergic Agent
        1.3.3 Histamine H₁-Receptor Antagonist
    1.4 Global Buclizine Market Size Estimates and Forecasts
        1.4.1 Global Buclizine Revenue 2018-2029
        1.4.2 Global Buclizine Sales 2018-2029
        1.4.3 Global Buclizine Market Average Price (2018-2029)
    1.5 Assumptions and Limitations

 2 Buclizine Market Competition by Manufacturers
    2.1 Global Buclizine Sales Market Share by Manufacturers (2018-2023)
    2.2 Global Buclizine Revenue Market Share by Manufacturers (2018-2023)
    2.3 Global Buclizine Average Price by Manufacturers (2018-2023)
    2.4 Global Buclizine Industry Ranking 2021 VS 2022 VS 2023
    2.5 Global Key Manufacturers of Buclizine, Manufacturing Sites & Headquarters
    2.6 Global Key Manufacturers of Buclizine, Product Type & Application
    2.7 Buclizine Market Competitive Situation and Trends
        2.7.1 Buclizine Market Concentration Rate
        2.7.2 The Global Top 5 and Top 10 Largest Buclizine Players Market Share by Revenue
        2.7.3 Global Buclizine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

 3 Buclizine Retrospective Market Scenario by Region
    3.1 Global Buclizine Market Size by Region: 2018 Versus 2022 Versus 2029
    3.2 Global Buclizine Global Buclizine Sales by Region: 2018-2029
        3.2.1 Global Buclizine Sales by Region: 2018-2023
        3.2.2 Global Buclizine Sales by Region: 2024-2029
    3.3 Global Buclizine Global Buclizine Revenue by Region: 2018-2029
        3.3.1 Global Buclizine Revenue by Region: 2018-2023
        3.3.2 Global Buclizine Revenue by Region: 2024-2029
    3.4 North America Buclizine Market Facts & Figures by Country
        3.4.1 North America Buclizine Market Size by Country: 2018 VS 2022 VS 2029
        3.4.2 North America Buclizine Sales by Country (2018-2029)
        3.4.3 North America Buclizine Revenue by Country (2018-2029)
        3.4.4 United States
        3.4.5 Canada
    3.5 Europe Buclizine Market Facts & Figures by Country
        3.5.1 Europe Buclizine Market Size by Country: 2018 VS 2022 VS 2029
        3.5.2 Europe Buclizine Sales by Country (2018-2029)
        3.5.3 Europe Buclizine Revenue by Country (2018-2029)
        3.5.4 Germany
        3.5.5 France
        3.5.6 U.K.
        3.5.7 Italy
        3.5.8 Russia
    3.6 Asia Pacific Buclizine Market Facts & Figures by Country
        3.6.1 Asia Pacific Buclizine Market Size by Country: 2018 VS 2022 VS 2029
        3.6.2 Asia Pacific Buclizine Sales by Country (2018-2029)
        3.6.3 Asia Pacific Buclizine Revenue by Country (2018-2029)
        3.6.4 China
        3.6.5 Japan
        3.6.6 South Korea
        3.6.7 India
        3.6.8 Australia
        3.6.9 China Taiwan
        3.6.10 Indonesia
        3.6.11 Thailand
        3.6.12 Malaysia
    3.7 Latin America Buclizine Market Facts & Figures by Country
        3.7.1 Latin America Buclizine Market Size by Country: 2018 VS 2022 VS 2029
        3.7.2 Latin America Buclizine Sales by Country (2018-2029)
        3.7.3 Latin America Buclizine Revenue by Country (2018-2029)
        3.7.4 Mexico
        3.7.5 Brazil
        3.7.6 Argentina
    3.8 Middle East and Africa Buclizine Market Facts & Figures by Country
        3.8.1 Middle East and Africa Buclizine Market Size by Country: 2018 VS 2022 VS 2029
        3.8.2 Middle East and Africa Buclizine Sales by Country (2018-2029)
        3.8.3 Middle East and Africa Buclizine Revenue by Country (2018-2029)
        3.8.4 Turkey
        3.8.5 Saudi Arabia
        3.8.6 UAE

 4 Segment by Type
    4.1 Global Buclizine Sales by Type (2018-2029)
        4.1.1 Global Buclizine Sales by Type (2018-2023)
        4.1.2 Global Buclizine Sales by Type (2024-2029)
        4.1.3 Global Buclizine Sales Market Share by Type (2018-2029)
    4.2 Global Buclizine Revenue by Type (2018-2029)
        4.2.1 Global Buclizine Revenue by Type (2018-2023)
        4.2.2 Global Buclizine Revenue by Type (2024-2029)
        4.2.3 Global Buclizine Revenue Market Share by Type (2018-2029)
    4.3 Global Buclizine Price by Type (2018-2029)

 5 Segment by Application
    5.1 Global Buclizine Sales by Application (2018-2029)
        5.1.1 Global Buclizine Sales by Application (2018-2023)
        5.1.2 Global Buclizine Sales by Application (2024-2029)
        5.1.3 Global Buclizine Sales Market Share by Application (2018-2029)
    5.2 Global Buclizine Revenue by Application (2018-2029)
        5.2.1 Global Buclizine Revenue by Application (2018-2023)
        5.2.2 Global Buclizine Revenue by Application (2024-2029)
        5.2.3 Global Buclizine Revenue Market Share by Application (2018-2029)
    5.3 Global Buclizine Price by Application (2018-2029)

 6 Key Companies Profiled
    6.1 Stuart Pharmaceuticals
        6.1.1 Stuart Pharmaceuticals Corporation Information
        6.1.2 Stuart Pharmaceuticals Description and Business Overview
        6.1.3 Stuart Pharmaceuticals Buclizine Sales, Revenue and Gross Margin (2018-2023)
        6.1.4 Stuart Pharmaceuticals Buclizine Product Portfolio
        6.1.5 Stuart Pharmaceuticals Recent Developments/Updates
    6.2 Laboratorios Rocnarf
        6.2.1 Laboratorios Rocnarf Corporation Information
        6.2.2 Laboratorios Rocnarf Description and Business Overview
        6.2.3 Laboratorios Rocnarf Buclizine Sales, Revenue and Gross Margin (2018-2023)
        6.2.4 Laboratorios Rocnarf Buclizine Product Portfolio
        6.2.5 Laboratorios Rocnarf Recent Developments/Updates
    6.3 UCB
        6.3.1 UCB Corporation Information
        6.3.2 UCB Description and Business Overview
        6.3.3 UCB Buclizine Sales, Revenue and Gross Margin (2018-2023)
        6.3.4 UCB Buclizine Product Portfolio
        6.3.5 UCB Recent Developments/Updates
    6.4 Mankind Pharma
        6.4.1 Mankind Pharma Corporation Information
        6.4.2 Mankind Pharma Description and Business Overview
        6.4.3 Mankind Pharma Buclizine Sales, Revenue and Gross Margin (2018-2023)
        6.4.4 Mankind Pharma Buclizine Product Portfolio
        6.4.5 Mankind Pharma Recent Developments/Updates
    6.5 Johnson and Johnson
        6.5.1 Johnson and Johnson Corporation Information
        6.5.2 Johnson and Johnson Description and Business Overview
        6.5.3 Johnson and Johnson Buclizine Sales, Revenue and Gross Margin (2018-2023)
        6.5.4 Johnson and Johnson Buclizine Product Portfolio
        6.5.5 Johnson and Johnson Recent Developments/Updates
    6.6 Meider Pharma
        6.6.1 Meider Pharma Corporation Information
        6.6.2 Meider Pharma Description and Business Overview
        6.6.3 Meider Pharma Buclizine Sales, Revenue and Gross Margin (2018-2023)
        6.6.4 Meider Pharma Buclizine Product Portfolio
        6.6.5 Meider Pharma Recent Developments/Updates
    6.7 Sanofi
        6.6.1 Sanofi Corporation Information
        6.6.2 Sanofi Description and Business Overview
        6.6.3 Sanofi Buclizine Sales, Revenue and Gross Margin (2018-2023)
        6.4.4 Sanofi Buclizine Product Portfolio
        6.7.5 Sanofi Recent Developments/Updates
    6.8 MK Pharma
        6.8.1 MK Pharma Corporation Information
        6.8.2 MK Pharma Description and Business Overview
        6.8.3 MK Pharma Buclizine Sales, Revenue and Gross Margin (2018-2023)
        6.8.4 MK Pharma Buclizine Product Portfolio
        6.8.5 MK Pharma Recent Developments/Updates
    6.9 HUA Shin Chemical Pharmaceutical
        6.9.1 HUA Shin Chemical Pharmaceutical Corporation Information
        6.9.2 HUA Shin Chemical Pharmaceutical Description and Business Overview
        6.9.3 HUA Shin Chemical Pharmaceutical Buclizine Sales, Revenue and Gross Margin (2018-2023)
        6.9.4 HUA Shin Chemical Pharmaceutical Buclizine Product Portfolio
        6.9.5 HUA Shin Chemical Pharmaceutical Recent Developments/Updates
    6.10 Peili Pharmaceutical
        6.10.1 Peili Pharmaceutical Corporation Information
        6.10.2 Peili Pharmaceutical Description and Business Overview
        6.10.3 Peili Pharmaceutical Buclizine Sales, Revenue and Gross Margin (2018-2023)
        6.10.4 Peili Pharmaceutical Buclizine Product Portfolio
        6.10.5 Peili Pharmaceutical Recent Developments/Updates
    6.11 Pfizer
        6.11.1 Pfizer Corporation Information
        6.11.2 Pfizer Buclizine Description and Business Overview
        6.11.3 Pfizer Buclizine Sales, Revenue and Gross Margin (2018-2023)
        6.11.4 Pfizer Buclizine Product Portfolio
        6.11.5 Pfizer Recent Developments/Updates
    6.12 Sinphar
        6.12.1 Sinphar Corporation Information
        6.12.2 Sinphar Buclizine Description and Business Overview
        6.12.3 Sinphar Buclizine Sales, Revenue and Gross Margin (2018-2023)
        6.12.4 Sinphar Buclizine Product Portfolio
        6.12.5 Sinphar Recent Developments/Updates
    6.13 Al Pharm
        6.13.1 Al Pharm Corporation Information
        6.13.2 Al Pharm Buclizine Description and Business Overview
        6.13.3 Al Pharm Buclizine Sales, Revenue and Gross Margin (2018-2023)
        6.13.4 Al Pharm Buclizine Product Portfolio
        6.13.5 Al Pharm Recent Developments/Updates

 7 Industry Chain and Sales Channels Analysis
    7.1 Buclizine Industry Chain Analysis
    7.2 Buclizine Key Raw Materials
        7.2.1 Key Raw Materials
        7.2.2 Raw Materials Key Suppliers
    7.3 Buclizine Production Mode & Process
    7.4 Buclizine Sales and Marketing
        7.4.1 Buclizine Sales Channels
        7.4.2 Buclizine Distributors
    7.5 Buclizine Customers

 8 Buclizine Market Dynamics
    8.1 Buclizine Industry Trends
    8.2 Buclizine Market Drivers
    8.3 Buclizine Market Challenges
    8.4 Buclizine Market Restraints

 9 Research Finding and Conclusion

 10 Methodology and Data Source
    10.1 Methodology/Research Approach
        10.1.1 Research Programs/Design
        10.1.2 Market Size Estimation
        10.1.3 Market Breakdown and Data Triangulation
    10.2 Data Source
        10.2.1 Secondary Sources
        10.2.2 Primary Sources
    10.3 Author List
    10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock